Oral Herbal Combination Formulation and Hair Growth in Women

Exclusion Criteria

• •Subjects should be generally healthy and have no smoking history in the past one year.
• •Subjects must have no history of diabetes, metabolic syndrome, HIV, immune deficiency, autoimmune disease known cardiovascular disease, malignancy, kidney disease, or chronic steroid use.
• •Women who are pregnant, planning to become pregnant or breastfeeding
• •Those who are unable to discontinue medicated shampoos or topical scalp medications for two weeks prior to and during the study.
• •Those who are unable to discontinue supplements containing Eclipta alba, Emblica officinalis, Centella asiatica and Hibiscus sabdariffa for one month prior to starting the study
• •Those who have a known allergy to Eclipta alba, Emblica officinalis, Centella asiatica or Hibiscus sabdariffa
• •Use of hair regrowth products in the previous 6 months
• •Using or planned use of non-breathable wigs
• •Those with a history of hair transplantation procedure
• •Presence of other dermatological disorders causing alopecia
• •Chemotherapy, radiation therapy or laser therapy (of scalp) in the last 6 months
• •Light therapy in the past 3 months
• •Participants using hormonal birth control unless on a stable / unchanged regimen for at least 3 months.
• •Systemic treatment during the last 3 months before study inclusion that could interfere with the study medications (ie, minoxidil, corticosteroids, Aminexil, topical estrogens, ketoconazole, beta blocker, cimetidine, diazoxide, isotretinoin or vitamin A intake \>10,000 IU/d)
• •Use of ocular prostaglandins for less than 4 months before first study visit
• •Those that are prisoners or cognitively impaired